These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


156 related items for PubMed ID: 4061454

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Osteomalacia and osteitis fibrosa in a man ingesting aluminum hydroxide antacid.
    Carmichael KA, Fallon MD, Dalinka M, Kaplan FS, Axel L, Haddad JG.
    Am J Med; 1984 Jun; 76(6):1137-43. PubMed ID: 6328994
    [Abstract] [Full Text] [Related]

  • 4. Bone aluminum and histomorphometric features of renal osteodystrophy.
    Hodsman AB, Sherrard DJ, Alfrey AC, Ott S, Brickman AS, Miller NL, Maloney NA, Coburn JW.
    J Clin Endocrinol Metab; 1982 Mar; 54(3):539-46. PubMed ID: 7056841
    [Abstract] [Full Text] [Related]

  • 5. Elevated bone aluminum content in dialysis patients without osteomalacia.
    McCarthy JT, Kurtz SB, McCall JT.
    Mayo Clin Proc; 1985 May; 60(5):315-20. PubMed ID: 3990380
    [Abstract] [Full Text] [Related]

  • 6. [Review on internal medicine, 1984. Electrolyte disturbance. III-3. Renal osteodystrophy].
    Ogura Y.
    Nihon Naika Gakkai Zasshi; 1985 Jun; 74(6):726-30. PubMed ID: 4045286
    [No Abstract] [Full Text] [Related]

  • 7. Renal osteodystrophy.
    Coburn JW, Henry DA.
    Adv Intern Med; 1984 Jun; 30():387-424. PubMed ID: 6397042
    [Abstract] [Full Text] [Related]

  • 8. Renal osteodystrophy--pathogenesis and treatment.
    Cushner HM, Adams ND.
    Am J Med Sci; 1985 Dec; 290(6):234-45. PubMed ID: 3909812
    [Abstract] [Full Text] [Related]

  • 9. Review: Renal osteodystrophy--pathogenesis and treatment.
    Cushner HM, Adams ND.
    Am J Med Sci; 1986 Apr; 291(4):264-75. PubMed ID: 3518448
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Aluminum - related osteomalacia.
    Ott SM.
    Int J Artif Organs; 1983 Jul; 6(4):173-5. PubMed ID: 6629522
    [No Abstract] [Full Text] [Related]

  • 13. Aluminum toxicity in patients undergoing dialysis: radiographic findings and prediction of bone biopsy results.
    Kriegshauser JS, Swee RG, McCarthy JT, Hauser MF.
    Radiology; 1987 Aug; 164(2):399-403. PubMed ID: 3602376
    [Abstract] [Full Text] [Related]

  • 14. The clinical spectrum of renal osteodystrophy in 57 chronic hemodialysis patients: a correlation between biochemical parameters and bone pathology findings.
    Chazan JA, Libbey NP, London MR, Pono L, Abuelo JG.
    Clin Nephrol; 1991 Feb; 35(2):78-85. PubMed ID: 2019018
    [Abstract] [Full Text] [Related]

  • 15. Osteomalacia and bone disease arising from aluminum.
    Coburn JW, Norris KC, Nebeker HG.
    Semin Nephrol; 1986 Mar; 6(1):68-89. PubMed ID: 3110896
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Dialysis osteomalacia: clinical aspects and physiopathological mechanisms.
    Drüeke T, Cournot-Witmer G.
    Clin Nephrol; 1985 Mar; 24 Suppl 1():S26-9. PubMed ID: 3915957
    [Abstract] [Full Text] [Related]

  • 20. Use of bone mineral content determination in the evaluation of osteodystrophy among hemodialysis patients.
    Heaf JG, Nielsen LP, Mogensen NB.
    Nephron; 1983 Mar; 35(2):103-7. PubMed ID: 6621754
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.